What a Prescriber Screens For Regardless of Product Every semaglutide label carries a boxed warning about the risk of thyroid C-cell tumors
ACHIEVE-2 Researchers enrolled 962 adults with type 2 diabetes who did not achieve glycemic control with metformin, had HbA1c of 7% to 10.5% and a BMI of 23 kg/m 2 or more at baseline (mean age, 56.1 years
It is unknown if semaglutide can cause thyroid tumors or medullary thyroid carcinoma (MTC) in humans
Initially developed for type 2 diabetes, GLP-1RAs have demonstrated robust weight loss in randomized controlled trials and real-world settings, leading to their repositioning as cornerstone obesity treatments ( Human metabolic studies consistently show that reductions in energy intake account for most of the weight loss observed during GLP-1RA therapy, whereas increases in resting energy expenditure are modest or absent ( Beyond total weight loss, the quality of weight loss has become an increasingly important clinical concern
Coverage for phentermine is more restricted since insurance plans usually wont cover weight loss medications
Select amount of bacteriostatic water to add (typically 1-3mL)
